Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression.
Biomed Pharmacother
; 118: 109258, 2019 Oct.
Article
in En
| MEDLINE
| ID: mdl-31545283
Full text:
1
Database:
MEDLINE
Traditional Medicines:
Medicinas_tradicionales_de_asia
/
Medicina_china
Main subject:
Disease Progression
/
Non-alcoholic Fatty Liver Disease
/
Gastrointestinal Microbiome
Language:
En
Journal:
Biomed Pharmacother
Year:
2019
Type:
Article